In this study, we used FISH to evaluate the c-MYC gene amplification status in the CTC and, accordingly, matched tumor tissues obtained from GC patients to evaluate whether CTC can replace tissue sampling for the determination of the c-MYC status in GC patients. This evidence concerns the gene MYC and neoplasm.